Scientists tracked 107 patients with extensively drug-resistant TB, also known as XDR-TB in three South African provinces between 2008 and 2012. Despite most patients being treated with about eight TB drugs, 78 died.
More than 40 others were released from hospitals without further monitoring. TB is an infectious bacterial infection that usually affects the lungs and is often spread by coughing and sneezing.
In one case, DNA testing confirmed a discharged patient passed on the deadly strain to his brother; both eventually died without being admitted to a hospital.
"These patients can survive for months or even years and are contributing to the community-based spread of XDR-TB," said Keertan Dheda of the University of Cape Town in South Africa, who led the study.
The research was published online today in the journal, Lancet. Dheda described the situation as alarming and called for modern sanatoriums to be built so patients could be treated away from society.
South Africa has the world's highest number of patients with XDR-TB and health officials warn other drug-resistant forms of the disease are spreading at an increasing rate, most notably in eastern and central Europe, China, India and Africa.
Globally, experts estimate only about one in five people with drug-resistant TB is diagnosed or treated.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
